Investing in Japan

Healthcare

Full text(1.6MB) March 2012

---

Executive Summary

A Market that is Expanding as the Population Ages

As Japan's population ages more rapidly than that of any other developed country, the healthcare and welfare markets in Japan are expected to expand significantly in the future. In response to the public's increased awareness of health issues and the government's implementation of supportive policies, the market is showing signs of developing new fields that include preventive medicine and nursing care services with emphasis on the prevention of age-related diseases.

Emergence of New Business Opportunities

The ever changing and expanding healthcare and welfare market in Japan has contributed to developing many new business opportunities; for example, in generics, over-the-counter drugs (OTCs), and health management services. In addition, novel drugs and medical devices, including biopharmaceuticals and nanomedicines, are under development. Companies from other industries are also entering the market, leading to dynamic business activities.

Government Supports Healthcare and Welfare as a Key Sector

The Japanese healthcare and welfare industry, which promises the expansion of domestic demand as a result of the aging society, is expected to serve as an engine for the entire economy of the nation. The government regards the industry as one of the strategic areas, and has been implementing various deregulation and other incentive policies.

Regional Opportunities

Manufacturers of drugs and medical devices are strategically taking advantage of regional benefits in marketing their products to manage their businesses effectively. Local governments have also been engaged in improving the business environment to invite foreign companies.